search
Back to results

HEBE Project - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases (HEBE)

Primary Purpose

Aging

Status
Active
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Physical exercise
Sponsored by
University of Milan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Aging focused on measuring chronic inflammation, physical exercise, lifestyle, prevention

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Being an employee of UMilan of both sexes and of any age (18-70 years); For the 100 chosen subjects identified for Phase 2: declare that they do not carry out physical activities at a competitive level and that you are committed about improving your own lifestyle. Exclusion Criteria: Previous myocardial infarction Autoimmune diseases Neurodegenerative pathologies Psychiatric pathologies Cardiac arrhythmias Chronic obstructive pulmonary disease osteo-muscular problems that prevent the execution of physical activity; oncological pathologies in the last 3 years that have required chemotherapy or immunotherapy; pregnancy/nursing/intention to become pregnant.

Sites / Locations

  • University of Milan

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Physical exercise prescription

Arm Description

Prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at baseline and after 6 months, biological samples will be collected (blood, urine, saliva and nasal swab)

Outcomes

Primary Outcome Measures

Change in maximal oxygen consumption (VO2 max)
The maximum or optimum rate at which the heart, lungs, and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.

Secondary Outcome Measures

Full Information

First Posted
March 1, 2023
Last Updated
April 3, 2023
Sponsor
University of Milan
Collaborators
Istituto Auxologico Italiano, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
search

1. Study Identification

Unique Protocol Identification Number
NCT05815732
Brief Title
HEBE Project - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases
Acronym
HEBE
Official Title
HEBE - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases. Research Line 1. Proof of Concept
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 8, 2022 (Actual)
Primary Completion Date
February 22, 2023 (Actual)
Study Completion Date
July 20, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Milan
Collaborators
Istituto Auxologico Italiano, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main objective of this clinical trial is to test the effects of the personalized intervention based on physical exercise, on clinical variables and circulating markers, in a population of employees of the University of Milan (UMilan). The HEBE study will include two phases: PHASE 1: All UMilan employees will be asked to voluntarily complete an anonymous online questionnaire, in order to gather information about their lifestyle (physical activity, diet, cigarette smoking, etc) (zero time: T0); at the end of the compilation, indications on how to improve the lifestyle will be provided. These indications will also be present and available for consultation in a special section of the site on the "HEBE" site, with UMilan domain (www.hebe.unimi.it). After 6 months, all UMilan employees will receive a second invitation to voluntarily complete the same questionnaire, in order to evaluate any changes, in terms of lifestyle improvement (time one: T1). PHASE 2: 100 eligible subjects who have expressed their availability in the initial questionnaire, will be identified to undergo a lifestyle improvement protocol based mainly on the prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at T0 and T1 (after 6 months), biological samples will be collected (blood, urine, saliva and nasal swab), which will be used to: i) set up a biobank shared by the members of the HEBE consortium; ii) identify biomarkers able to monitor the effect of physical exercise on the characteristics of the frailty under examination. Furthermore, both at T0 and T1 questionnaires will be completed and carried out clinical evaluations (anamnesis, physical examination, tests for the study of the autonomic nervous system, bio-impedance test, evaluation/estimate of maximal oxygen consumption, ECG).
Detailed Description
Non-communicable diseases (NCDs) are the cause of premature aging and death of 41 million people each year, accounting for 71% of all deaths globally. NCDs are closely linked to rapid urbanization and globalization. In this context, unsustainable lifestyles, characterized by a lack of physical activity, trigger the progression of NCDs. To date, it is estimated that around 41% of Europeans (and as many as 60% of Italians) do not engage in any type of physical activity (even light) during the week and this increases the risk of chronic diseases: 86% of deaths are attributable to cardiovascular disease, cancer, chronic respiratory disease and type 2 diabetes, a disease from which approximately 52 million people suffer in Europe (8.4% of men and 7.8% of women among 20 and 79 years of age). Over the years, the progressive increase in the number of senescent cells can lead to tissue/organ dysfunction. In an attempt to respond to this process, senescent cells undergo metabolic modifications leading to increased secretion of soluble factors (e.g. cytokines, chemokines, growth factors, metalloproteases), which thus modulate their microenvironment through the removal of damaged cells by the recruitment of phagocytes and stimulating cell differentiation and proliferation for tissue renewal. The secretion of pro-inflammatory molecules and the activation of immune cells contributes to the generation of a low-grade chronic pro-inflammatory state known as "inflammaging", which is at the root of most age-related diseases. Furthermore, upregulation of mitogenic and pro-angiogenic pathways dangerously increases the risk of oncogenic transformation. The modulation of the complex of alterations that make up inflammaging could therefore be the key to guaranteeing healthy aging and reducing the risk of developing early NCD. A very promising approach to controlling inflammaging involves focusing on reducing the risk factors associated with these diseases by proposing alternative development models. The main challenge of the HEBE project as a whole therefore consists in addressing three fundamental questions: What primary prevention approaches can we develop, considering all phases of the individual's life, to ensure an improvement in the quality of life and health status of the population, with a positive impact on the socio-economic system of the area? What intervention protocols based on physical exercise, combined with diet and any pharmacological/pharmaceutical approach, can we propose to frail subjects, in order to intervene on "inflammaging", to increase life expectancy and healthy ageing? Which inflammaging markers (biomarkers and other clinical indicators) can we measure and integrate to define the risk of developing NCD, especially in frail subjects, to guide integrated personalized preventive interventions (precision/personalized healthcare)? General objectives of the trial The main objective of this study is the evaluation of the effects of the personalized intervention based on physical exercise, on clinical parameters and circulating markers, in a population of employees of the University of Milan (UMilan). In Research Line 1- a pilot study will be conducted involving UMilan employees which will include two phases: PHASE 1: All UMilan employees will be asked to voluntarily complete an anonymous online questionnaire, in order to gather information about their lifestyle (physical activity, diet, cigarette smoking, etc.) (zero time: T0); at the end of the compilation, indications on how to improve the lifestyle will be provided. These indications will also be present and available for consultation in a special section of the site on the "HEBE" site, with UMilan domain (www.hebe.unimi.it), in a special section. After 6 months, all UMilan employees will receive a second invitation to voluntarily complete the same questionnaire, in order to evaluate any changes, in terms of lifestyle improvement (time one: T1). PHASE 2: 100 eligible subjects who have expressed their availability in the initial questionnaire, will be identified to undergo a lifestyle improvement protocol based mainly on the prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency, and progression of the exercise. For each subject, at T0 and T1 (after 6 months), biological samples will be collected (blood, urine, saliva and nasal swab), which will be used to: i) set up a biobank shared by the members of the HEBE consortium; ii) identify biomarkers able to monitor the effect of physical exercise on the characteristics of the frailty under examination. Furthermore, both at T0 and T1 questionnaires will be completed and carried out clinical evaluations (anamnesis, physical examination, tests for the study of the autonomic nervous system, bio-impedance test, evaluation/estimate of maximal oxygen consumption, ECG) useful for: i) verifying the clinical conditions of the subject; ii) obtain useful parameters for the customized definition of the intervention program; iii) verify the effectiveness of the intervention at T1; iv) assess the association between clinical indicators and biomarkers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging
Keywords
chronic inflammation, physical exercise, lifestyle, prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Participants will be assessed before and after the intervention with physical exercise and personalized lifestyle advice.
Masking
None (Open Label)
Allocation
N/A
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physical exercise prescription
Arm Type
Experimental
Arm Description
Prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at baseline and after 6 months, biological samples will be collected (blood, urine, saliva and nasal swab)
Intervention Type
Other
Intervention Name(s)
Physical exercise
Intervention Description
Personalized exercise program, with defined modalities, intensity, duration, frequency and progression of the exercise.
Primary Outcome Measure Information:
Title
Change in maximal oxygen consumption (VO2 max)
Description
The maximum or optimum rate at which the heart, lungs, and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.
Time Frame
Change from baseline VO2 max at six months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Being an employee of UMilan of both sexes and of any age (18-70 years); For the 100 chosen subjects identified for Phase 2: declare that they do not carry out physical activities at a competitive level and that you are committed about improving your own lifestyle. Exclusion Criteria: Previous myocardial infarction Autoimmune diseases Neurodegenerative pathologies Psychiatric pathologies Cardiac arrhythmias Chronic obstructive pulmonary disease osteo-muscular problems that prevent the execution of physical activity; oncological pathologies in the last 3 years that have required chemotherapy or immunotherapy; pregnancy/nursing/intention to become pregnant.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elia M Biganzoli, PhD
Organizational Affiliation
University of Milan
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Daniela Lucini, PhD
Organizational Affiliation
University of Milan
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Valentina Bollati, PhD
Organizational Affiliation
University of Milan
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Francesca Bianchi, PhD
Organizational Affiliation
University of Milan
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chiara Mandò, PhD
Organizational Affiliation
University of Milan
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mario Clerici, PhD
Organizational Affiliation
University of Milan
Official's Role
Study Chair
Facility Information:
Facility Name
University of Milan
City
Milano
ZIP/Postal Code
20122
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
The plan is going to be agreed with all the 140 participants Researchers of UMilan of the HEBE project with a Consortium Agreement
Links:
URL
https://hebe.unimi.it/
Description
HEBE project website

Learn more about this trial

HEBE Project - Healthy Aging Versus Inflamm-aging: the Role of Physical Exercise in Modulating the Biomarkers of Age-associated and Environmentally Determined Chronic Diseases

We'll reach out to this number within 24 hrs